Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Mymd Pharmaceuticals Inc

CUSIP: 62856X952 | 3 institutional holders

Quarters

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile